Skip to main content
Top
Published in: Supportive Care in Cancer 2/2016

01-02-2016 | Original Article

Diagnostic accuracy of the Catheter Injection and Aspiration (CINAS) classification for assessing the function of totally implantable venous access devices

Authors: G. A. Goossens, Y. De Waele, M. Jérôme, S. Fieuws, C. Janssens, M. Stas, P. Moons

Published in: Supportive Care in Cancer | Issue 2/2016

Login to get access

Abstract

Purpose

Intravenous catheters are used for the administration of intravenous therapy and for blood sampling. These devices are considered as well-functioning if both the injection and aspiration are easy. Malfunction is frequently observed and usually vaguely described as occlusion. We developed the CINAS, the Catheter Injection and Aspiration scheme. The CINAS is a catheter function classification tool, which classifies both the injection and the aspiration ability in a uniform way. Each CINAS class consists of a combination of an injection (IN) and an aspiration (AS) code: e.g. IN1AS1 is the CINAS class for a well-functioning catheter. In this series, we aimed to determine the accuracy of the CINAS class reported by nurses, after minimal training, versus a trained researcher, acting as a reference standard.

Methods

Catheter function was assessed during a standard blood sampling procedure through a totally implantable venous access device in a convenience sample of 150 oncology patients. One nurse researcher and 111 oncology nurses both scored the catheter function according to the CINAS classification scheme, independently. Concordance between the scores was calculated.

Results

For the 140 catheters scored as well-functioning (IN1AS1 score) by the researcher, 139 or 99.3 % (95 % confidence interval (CI) 96.1–99.9 %) were scored correctly by the nurse participants. Nine out of ten or 90 % (95 % CI 55.5–98.3 %) of malfunctioning catheters (researcher scores different from IN1AS1) were also identified as malfunctioning by the nurse participants and received exactly the same CINAS score in eight cases (80 %, 95 % CI 44.4–97.5 %). The overall accuracy of the CINAS scored by the nurse participants versus the researcher is (139 + 9)/150 or 98.7 % (95 % CI 95.3–99.8 %).

Conclusions

Nurse participants were able to classify the catheter function of totally implantable venous access devices with the CINAS accurately after a brief explanation about the classification options.
Literature
2.
go back to reference Pikwer A, Baath L, Davidson B, Perstoft I, Akeson J (2008) The incidence and risk of central venous catheter malpositioning: a prospective cohort study in 1619 patients. Anaesth Intensive Care 36:30–37PubMed Pikwer A, Baath L, Davidson B, Perstoft I, Akeson J (2008) The incidence and risk of central venous catheter malpositioning: a prospective cohort study in 1619 patients. Anaesth Intensive Care 36:30–37PubMed
3.
go back to reference Skaff ER, Doucette S, McDiarmid S, Huebsch L, Sabloff M (2012) Vascular access devices in leukemia: a retrospective review amongst patients treated at the Ottawa Hospital with induction chemotherapy for acute leukemia. Leuk Lymphoma 53:1090–1095. doi:10.3109/10428194.2011.639879 PubMedCrossRef Skaff ER, Doucette S, McDiarmid S, Huebsch L, Sabloff M (2012) Vascular access devices in leukemia: a retrospective review amongst patients treated at the Ottawa Hospital with induction chemotherapy for acute leukemia. Leuk Lymphoma 53:1090–1095. doi:10.​3109/​10428194.​2011.​639879 PubMedCrossRef
4.
go back to reference Cesaro S, Corro R, Pelosin A, Gamba P, Zadra N, Fusaro F, Pillon M, Cusinato R, Zampieri C, Magagna L, Cavaliere M, Tridello G, Zanon G, Zanesco L (2004) A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases. Ann Hematol 83:183–188. doi:10.1007/s00277-003-0796-9 PubMedCrossRef Cesaro S, Corro R, Pelosin A, Gamba P, Zadra N, Fusaro F, Pillon M, Cusinato R, Zampieri C, Magagna L, Cavaliere M, Tridello G, Zanon G, Zanesco L (2004) A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases. Ann Hematol 83:183–188. doi:10.​1007/​s00277-003-0796-9 PubMedCrossRef
5.
go back to reference Lim MY, Al-Kali A, Ashrani AA, Begna KH, Elliott MA, Hogan WJ, Hook CC, Kaufmann SH, Letendre L, Litzow MR, Patnaik MS, Pardanani A, Tefferi A, Wolanskyj AP, Grill DE, Pruthi RK (2013) Comparison of complication rates of Hickman (®) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy. Leuk Lymphoma 54:1263–1267. doi:10.3109/10428194.2012.742520 PubMedCrossRef Lim MY, Al-Kali A, Ashrani AA, Begna KH, Elliott MA, Hogan WJ, Hook CC, Kaufmann SH, Letendre L, Litzow MR, Patnaik MS, Pardanani A, Tefferi A, Wolanskyj AP, Grill DE, Pruthi RK (2013) Comparison of complication rates of Hickman (®) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy. Leuk Lymphoma 54:1263–1267. doi:10.​3109/​10428194.​2012.​742520 PubMedCrossRef
6.
go back to reference Surov A, Wienke A, Carter JM, Stoevesandt D, Behrmann C, Spielmann RP, Werdan K, Buerke M (2009) Intravascular embolization of venous catheter—causes, clinical signs, and management: a systematic review. JPEN J Parenter Enteral Nutr 33:677–685. doi:10.1177/0148607109335121 PubMedCrossRef Surov A, Wienke A, Carter JM, Stoevesandt D, Behrmann C, Spielmann RP, Werdan K, Buerke M (2009) Intravascular embolization of venous catheter—causes, clinical signs, and management: a systematic review. JPEN J Parenter Enteral Nutr 33:677–685. doi:10.​1177/​0148607109335121​ PubMedCrossRef
7.
go back to reference Stephens LC, Haire WD, Kotulak GD (1995) Are clinical signs accurate indicators of the cause of central venous catheter occlusion? JPEN J Parenter Enteral Nutr 19:75–79PubMedCrossRef Stephens LC, Haire WD, Kotulak GD (1995) Are clinical signs accurate indicators of the cause of central venous catheter occlusion? JPEN J Parenter Enteral Nutr 19:75–79PubMedCrossRef
8.
go back to reference Baskin JL, Pui CH, Reiss U, Wilimas JA, Metzger ML, Ribeiro RC, Howard SC (2009) Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 374:159–169PubMedPubMedCentralCrossRef Baskin JL, Pui CH, Reiss U, Wilimas JA, Metzger ML, Ribeiro RC, Howard SC (2009) Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 374:159–169PubMedPubMedCentralCrossRef
9.
go back to reference Nakazawa N (2010) Infectious and thrombotic complications of central venous catheters. Semin Oncol Nurs 26:121–131PubMedCrossRef Nakazawa N (2010) Infectious and thrombotic complications of central venous catheters. Semin Oncol Nurs 26:121–131PubMedCrossRef
10.
go back to reference Goossens GA, Vrebos M, De Wever I, Stas M (2004) Vacutainer filling time through subcutaneous venous access devices. J Vasc Access 5:154–160PubMed Goossens GA, Vrebos M, De Wever I, Stas M (2004) Vacutainer filling time through subcutaneous venous access devices. J Vasc Access 5:154–160PubMed
11.
go back to reference Verhamme P, Goossens G, Maleux G, Collen D, Stas M (2007) A dose-finding clinical trial of staphylokinase SY162 in patients with long-term venous access catheter thrombotic occlusion. J Thromb Thrombolysis 24:1–5PubMedCrossRef Verhamme P, Goossens G, Maleux G, Collen D, Stas M (2007) A dose-finding clinical trial of staphylokinase SY162 in patients with long-term venous access catheter thrombotic occlusion. J Thromb Thrombolysis 24:1–5PubMedCrossRef
12.
go back to reference Horne MK III, Mayo DJ (1997) Low-dose urokinase infusions to treat fibrinous obstruction of venous access devices in cancer patients. J Clin Oncol 15:2709–2714PubMed Horne MK III, Mayo DJ (1997) Low-dose urokinase infusions to treat fibrinous obstruction of venous access devices in cancer patients. J Clin Oncol 15:2709–2714PubMed
13.
go back to reference Frank JL, Garb JL, Halla B, Reed WP Jr (2001) Ionic implantation of silicone chronic venous access devices does not alter thrombotic complications: a double-blinded, randomized clinical trial. Surgery 129:547–551PubMedCrossRef Frank JL, Garb JL, Halla B, Reed WP Jr (2001) Ionic implantation of silicone chronic venous access devices does not alter thrombotic complications: a double-blinded, randomized clinical trial. Surgery 129:547–551PubMedCrossRef
14.
go back to reference Carlo JT, Lamont JP, McCarty TM, Livingston S, Kuhn JA (2004) A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports. Am J Surg 188:722–727PubMedCrossRef Carlo JT, Lamont JP, McCarty TM, Livingston S, Kuhn JA (2004) A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports. Am J Surg 188:722–727PubMedCrossRef
15.
go back to reference Stevens B, Barton SE, Brechbill M, Moenter S, Piel AL, Shankle D (2000) A randomized, prospective trial of conventional vascular ports vs. the vortex “clear-flow” reservoir port in adult oncology patients. JVAD 5(4):37–40 Stevens B, Barton SE, Brechbill M, Moenter S, Piel AL, Shankle D (2000) A randomized, prospective trial of conventional vascular ports vs. the vortex “clear-flow” reservoir port in adult oncology patients. JVAD 5(4):37–40
16.
go back to reference Johansson E, Bjorkholm M, Bjorvell H, Hast R, Takolander R, Olofsson P, Backman L, Weitzberg E, Engervall P (2004) Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia—a randomized study. Support Care Cancer 12:99–105PubMedCrossRef Johansson E, Bjorkholm M, Bjorvell H, Hast R, Takolander R, Olofsson P, Backman L, Weitzberg E, Engervall P (2004) Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia—a randomized study. Support Care Cancer 12:99–105PubMedCrossRef
17.
go back to reference Goossens GA, Stas M, Moons P (2012) Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 years of clinical experience. Eur J Oncol Nurs S1462-3889(11):00173–6. doi:10.1016/j.ejon.2011.11.006 Goossens GA, Stas M, Moons P (2012) Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 years of clinical experience. Eur J Oncol Nurs S1462-3889(11):00173–6. doi:10.​1016/​j.​ejon.​2011.​11.​006
18.
go back to reference Sauerland C, Engelking C, Wickham R, Corbi D (2006) Vesicant extravasation part I: mechanisms, pathogenesis, and nursing care to reduce risk. Oncol Nurs Forum 33:1134–1141PubMedCrossRef Sauerland C, Engelking C, Wickham R, Corbi D (2006) Vesicant extravasation part I: mechanisms, pathogenesis, and nursing care to reduce risk. Oncol Nurs Forum 33:1134–1141PubMedCrossRef
19.
go back to reference Goossens GA, Kerschaever I, Despierre E, Stas M (2013) Access of a fully rotated implantable port leads to extravasation. J Vasc Access 14:299–300. doi:10.5301/jva.5000136, C4F9D654-8A58-4478-A3A5-603E3616D9DB PubMedCrossRef Goossens GA, Kerschaever I, Despierre E, Stas M (2013) Access of a fully rotated implantable port leads to extravasation. J Vasc Access 14:299–300. doi:10.​5301/​jva.​5000136, C4F9D654-8A58-4478-A3A5-603E3616D9DB PubMedCrossRef
20.
21.
go back to reference Perez Fidalgo JA, Garcia FL, Cervantes A, Margulies A, Vidall C, Roila F (2012) Management of chemotherapy extravasation: ESMO–EONS Clinical Practice Guidelines. Eur J Oncol Nurs 16:528–534PubMedCrossRef Perez Fidalgo JA, Garcia FL, Cervantes A, Margulies A, Vidall C, Roila F (2012) Management of chemotherapy extravasation: ESMO–EONS Clinical Practice Guidelines. Eur J Oncol Nurs 16:528–534PubMedCrossRef
Metadata
Title
Diagnostic accuracy of the Catheter Injection and Aspiration (CINAS) classification for assessing the function of totally implantable venous access devices
Authors
G. A. Goossens
Y. De Waele
M. Jérôme
S. Fieuws
C. Janssens
M. Stas
P. Moons
Publication date
01-02-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 2/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2839-x

Other articles of this Issue 2/2016

Supportive Care in Cancer 2/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine